- AU$360.53m
- AU$2.81m
- AU$228.86m
- 89
- 80
- 38
- 76
Annual income statement for OFX, fiscal year end - March 31st, AUD millions except per share, conversion factor applied.
R2019 March 31st | 2020 March 31st | R2021 March 31st | R2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 130 | 138 | 135 | 158 | 229 |
| Cost of Revenue | |||||
| Gross Profit | 118 | 125 | 118 | 147 | 214 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 109 | 114 | 119 | 126 | 191 |
| Operating Profit | 21.6 | 24.8 | 15.6 | 32.7 | 37.5 |
| Net Income Before Taxes | 21.6 | 24.8 | 15.6 | 32.7 | 37.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 17.1 | 20.3 | 12.1 | 25 | 31.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 17.1 | 20.3 | 12.1 | 25 | 31.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 17.1 | 20.3 | 12.1 | 25 | 31.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.069 | 0.084 | 0.048 | 0.1 | 0.124 |
| Dividends per Share |